Healthcare 21 UK Expands Interventional Portfolio Through New Partnership with GMT Medical
Healthcare 21 UK (Aquilant) is excited to announce a new partnership with GMT Medical, a recognised provider of precision percutaneous needle biopsy products trusted by clinicians for their performance and reliability.
Adding GMT Medical’s biopsy range to the Healthcare 21 UK portfolio supports our commitment to giving healthcare professionals access to high quality, clinically proven technologies that enhance diagnostic accuracy and streamline patient pathways.
By combining GMT Medical’s expertise in biopsy solutions with Healthcare 21 UK’s growing presence in interventional radiology and minimally invasive care, this partnership will offer more choice, greater value and help support higher standards across the UK healthcare system.
United Kingdom
Ireland